Home / People / Prohibition PartnersReport: 650% Spike In Cannabis Medicine Trials Prioritizing Chronic And Neuropathic PainProhibition PartnersTue, Sep 19RT @JavierHasse: Report: 650% Spike In Cannabis Medicine Trials Prioritizing Chronic And Neuropathic Pain https://t.co/U8QUUna9Bu via @Benz…0Could the future of healthcare be intertwined with cannabis-based medicines?Read More Discover Prohibition PartnersNewsAddictionCannabisDispensaryHealthOpioidsPsychedelicsScience